KRAS mutation testing in clinical practice. - Wikidata - awgldk - TriplyDB

KRAS mutation testing in clinical practice.

KRAS mutation testing in clinical practice.

http://www.wikidata.org/entity/Q38285393

about

Digital PCR Improves Mutation Analysis in Pancreas Fine Needle Aspiration Biopsy Specimens.KRAS mutation of extraovarian implants of serous borderline tumor: prognostic indicator for adverse clinical outcome.

P2860

Q36261430-C0998E2C-352F-40CE-A70B-17B57425F114 Q50063073-1A99C8CD-0044-44BF-A314-CC4A237B5F02

P2860

KRAS mutation testing in clinical practice.

http://www.wikidata.org/entity/Q38285393

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

KRAS mutation testing in clinical practice.

@en

type

label

KRAS mutation testing in clinical practice.

@en

prefLabel

KRAS mutation testing in clinical practice.

@en

P1433

Q38285393-4B4B5F85-E879-47EF-ACD3-0B32702E1A6A

P1476

Q38285393-174D7349-BBDB-4538-870A-7658D686FAD7

P2093

Q38285393-D795A10F-7904-42A6-9D8A-0BCECF558208

Q38285393-E9B95811-9DA8-4C9F-A6B5-663387B2A235

P2860

Q38285393-097713EC-88A5-4EB8-951B-B309E6C68878

Q38285393-0E859771-D5FB-4F9F-8648-2222BD5DFD70

Q38285393-1842A201-C908-455C-A8FF-53B1E68F3E23

Q38285393-1F0AA7A0-3F3E-4127-B867-41F419FD068F

Q38285393-22A62BF9-036D-4391-9F63-1431836EBF3E

Q38285393-2310958A-4F90-4FAA-9CD2-6FF8A91CE776

Q38285393-23B83512-ECBF-4105-8C40-CB09E8C697B7

Q38285393-23DC7CD7-C678-4E6E-932D-24699752E8AE

Q38285393-24DC8B94-CF84-442A-85B8-21C3741B3B2B

Q38285393-29BCC92F-D3F0-4936-9BB4-03D0C605BA65

P304

Q38285393-D55E0107-D19E-4DFF-9CB8-BC8C6A491279

P31

Q38285393-331F19EB-FB0E-41AC-AD09-F2F72D496E69

P356

Q38285393-668FB768-62FF-4FC1-AFE7-1C51A76780AB

P433

Q38285393-04A9AD62-1B4E-44BB-87F9-7FD28D1D6E20

P478

Q38285393-C4AF817E-A312-40A4-9683-2388882B3310

P577

Q38285393-F377ED1E-6A29-4122-979F-37C7A991E87D

P698

Q38285393-5D5172A7-BA07-46E8-85E6-9819D0BE48CF

P356

14737159.2015.986102

P1433

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

P1476

KRAS mutation testing in clinical practice.

@en

P2093

Pei Hui

http://www.w3.org/2001/XMLSchema#string

Sudhir Perincheri

http://www.w3.org/2001/XMLSchema#string

P2860

The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803

Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

Genetic alterations during colorectal-tumor development

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

P304

375-384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737159.2015.986102

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25487540

http://www.w3.org/2001/XMLSchema#string